ZIM LABORATORIES LIMITED

ZIM LABORATORIES LIMITED We offer both pharmaceutical and nutraceutical products.

We are research driven pharmaceutical company who develop, manufacture and supply differentiated generic products in the oral solid dosage forms, both as pre-formulation intermediates as well as finished formulation for certain key therapeutic segments. We have in-house R&D capabilities to offer a range of non-infringing drug delivery solutions based on process technologies that bring patient compliance thereby reducing the cost of treatment.

07/01/2026

Uniformity in thin-film dosage forms is critical to meeting pharmacopeial standards for content accuracy and dissolution control.
Variations in film thickness can distort both dose delivery and release rate.

Thinoral® Technology maintains consistent thickness and API distribution, ensuring each film performs as intended, dose after dose.
To know more, get in touch with us: www.zimlab.in.


What an energizing few days at CPHI India.Returning to a forum that consistently brings together leaders across the phar...
05/01/2026

What an energizing few days at CPHI India.

Returning to a forum that consistently brings together leaders across the pharmaceutical value chain in India is always valuable.

Across the three days, discussions spanned evolving manufacturing expectations, quality-first approaches, supply resilience, and the shared responsibility of making pharmaceutical innovation more accessible and reliable.

To everyone who stopped by our booth, shared their expertise, and explored partnerships with us - thank you.

Already looking forward to continuing the conversations.

Close to 13% global pharmaceutical market share! India is one of the fastest-growing forces in the industry.Let’s collab...
02/01/2026

Close to 13% global pharmaceutical market share! India is one of the fastest-growing forces in the industry.

Let’s collaborate to be a part of this growth story. Get in touch with us through the link in bio!

[ZIMLabs, Finished dosage formulations, Pharmaceutical Formulation Development, Pharmaceutical Products Manufacturing company, Pharmaceutical manufacturer in india, Generic drug manufacturers in india, pharmaceutical manufacturer, pharmaceutical product development, sublingual, pharmaceutical formulation, novel dosage form, Oral Thin Films Products]

Every innovation starts with rigorous efforts, and every partnership thrives on shared vision. Here's to creating real i...
31/12/2025

Every innovation starts with rigorous efforts, and every partnership thrives on shared vision. Here's to creating real impact together in 2026.

#2026

30/12/2025

Patient-friendly oral therapies are built to combine scientific innovation with everyday convenience. This is exactly what MucoStrip® Technology enables.

Find out how we can help you through the link in bio!

[ZIMLabs, Finished dosage formulations, Pharmaceutical Formulation Development, Pharmaceutical Products Manufacturing company, Pharmaceutical manufacturer in india, Generic drug manufacturers in india, pharmaceutical manufacturer, pharmaceutical product development, sublingual, pharmaceutical formulation, novel dosage form, Oral Thin Films Products]

Innovation, dedication, and a little festive cheer… Here’s to progress that keeps getting brighter. Wishing you a Merry ...
25/12/2025

Innovation, dedication, and a little festive cheer… Here’s to progress that keeps getting brighter. Wishing you a Merry Christmas from all of us at ZIM Labs!

24/12/2025

Adapt your formulations to a robust platform for safer, more predictable drug delivery.

Find out how we can help you through the link in bio!

[ZIMLabs, Finished dosage formulations, Pharmaceutical Formulation Development, Pharmaceutical Products Manufacturing company, Pharmaceutical manufacturer in india, Generic drug manufacturers in india, pharmaceutical manufacturer, pharmaceutical product development, sublingual, pharmaceutical formulation, novel dosage form, Oral Thin Films Products]

Maintaining consistent plasma concentration remains a persistent challenge in controlled-release design.Pseudo-zero-orde...
22/12/2025

Maintaining consistent plasma concentration remains a persistent challenge in controlled-release design.

Pseudo-zero-order kinetics offers a solution: It sustains a saturated drug interface within a controlled polymeric or gel matrix. The release rate becomes a function of matrix properties, achieving near-constant delivery and steady pharmacological effect.

RGDRT leverages this principle through precise gel-matrix engineering to deliver predictable, sustained release profiles across diverse APIs. To know more, get in touch with us through the link in bio!

[ZIMLabs, Finished dosage formulations, Pharmaceutical Formulation Development, Pharmaceutical Products Manufacturing company, Pharmaceutical manufacturer in india, Generic drug manufacturers in india, pharmaceutical manufacturer, pharmaceutical product development, sublingual, pharmaceutical formulation, novel dosage form, Oral Thin Films Products]

Why sublingual delivery matters:When a drug is placed under the tongue, it diffuses through the mucosal membrane and ent...
19/12/2025

Why sublingual delivery matters:

When a drug is placed under the tongue, it diffuses through the mucosal membrane and enters the bloodstream via a dense capillary network.

The result: Bypassed hepatic first-pass metabolism, leading to faster onset and improved bioavailability.

The approach is particularly relevant for molecules with poor gastrointestinal stability or extensive hepatic metabolism.

By addressing both formulation performance and patient usability, we move closer to truly optimized drug delivery.

To learn more about us, click on the link in bio!

[ZIMLabs, Finished dosage formulations, Pharmaceutical Formulation Development, Pharmaceutical Products Manufacturing company, Pharmaceutical manufacturer in india, Generic drug manufacturers in india, pharmaceutical manufacturer, pharmaceutical product development, sublingual, pharmaceutical formulation, novel dosage form, Oral Thin Films Products]

17/12/2025

The right choice depends on how well the formulation bridges API solubility, dose, and absorption route.

A molecule suited for GI absorption performs differently when designed for mucosal delivery, and vice versa.

Choosing the appropriate category of film helps translate these formulation nuances into reliable, scalable thin-film products.

Reach out to us to optimize your delivery system. Click on the link in bio!

[ZIMLabs, Finished dosage formulations, Pharmaceutical Formulation Development, Pharmaceutical Products Manufacturing company, Pharmaceutical manufacturer in india, Generic drug manufacturers in india, pharmaceutical manufacturer, pharmaceutical product development, sublingual, pharmaceutical formulation, novel dosage form, Oral Thin Films Products]

In fixed-dose combinations, physical proximity isn’t always favourable. APIs in contact can undergo hydrolysis, oxidatio...
15/12/2025

In fixed-dose combinations, physical proximity isn’t always favourable.

APIs in contact can undergo hydrolysis, oxidation, or Maillard reactions, accelerating degradation and compromising potency.

Bilayer OTFs mitigate these risks by isolating each API within discrete layers, improving stability, extending shelf life, and supporting regulatory compliance in complex FDCs.

Mitigate degradation pathways while ensuring compliance with long-term stability requirements. To learn more about us, click on the link in bio!

[ZIMLabs, Finished dosage formulations, Pharmaceutical Formulation Development, Pharmaceutical Products Manufacturing company, Pharmaceutical manufacturer in india, Generic drug manufacturers in india, pharmaceutical manufacturer, pharmaceutical product development, sublingual, pharmaceutical formulation, novel dosage form, Oral Thin Films Products]

At a juncture where Oral Thin Films gain ground in global pharmaceutical manufacturing, pharmaceutical companies need CD...
13/12/2025

At a juncture where Oral Thin Films gain ground in global pharmaceutical manufacturing, pharmaceutical companies need CDMOs that offer solutions that are practical, scalable, and ready.

To explore how our expertise can support you, get in touch with us through the link in bio!

[ZIMLabs, Finished dosage formulations, Pharmaceutical Formulation Development, Pharmaceutical Products Manufacturing company, Pharmaceutical manufacturer in india, Generic drug manufacturers in india, pharmaceutical manufacturer, pharmaceutical product development, sublingual, pharmaceutical formulation, novel dosage form, Oral Thin Films Products]

Address

B-21/22, MIDC Area, Kalameshwar
Nagpur
441501

Opening Hours

Monday 9am - 5:30pm
Tuesday 9am - 5:30pm
Wednesday 9am - 5:30pm
Thursday 9am - 5:30pm
Friday 9am - 5:30pm
Saturday 9am - 5:30pm
Sunday 9am - 5:30pm

Telephone

07118271370

Website

Alerts

Be the first to know and let us send you an email when ZIM LABORATORIES LIMITED posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category